Nexien BioPharma Inc is a Denver-based company specializing in the research and development of cannabinoid pharmaceuticals in accordance with the regulatory pathways set by the United States Food and Drug Administration (FDA). They operate in strict compliance with DEA licensed pharmaceutical clinical research organizations, contract manufacturing partners, and prestigious academic research institutions, ensuring the highest standards of quality and safety.
The company focuses on three synergistic business development paths, which include developing, licensing, and commercializing cannabinoid-based medications for specific medical conditions and disorders, as well as the development and licensing of proprietary delivery systems for cannabinoid medications. Additionally, Nexien BioPharma Inc invests in companies and acquires technologies or medications focused on cannabinoid-based research through Special Purpose Vehicles (SPV) controlled by the company.
Generated from the website